July 19, 2021– Despite lifelong health challenges, Chicago resident Tracy Kimble exudes a spirit of perseverance and independence. But there was a time in his life when Tracy felt the despair of being forced to choose between supporting his family and supporting his health. That’s when UI Health in Chicago and the 340B drug pricing program intervened to provide the assistance … [Read more...]
Boehringer Ingelheim Joins in the Attacks on 340B
July 12, 2021– The pharmaceutical giant Boehringer Ingelheim (BI), a manufacturer headquartered in Germany, is the latest company to announce it is cutting off discounts to safety-net hospitals participating in the 340B drug pricing program. If BI goes through with its threat on Aug. 1, it will become the seventh drug company to limit 340B discounts despite strong warnings by … [Read more...]
As Losses Mount, 340B Pharmacy Dispute Takes Twists and Turns
By Maureen Testoni June 29, 2021– The year-long dispute over drug companies flouting the 340B statute and denying drug price discounts to hospitals, community health centers, and public health clinics partnering with community pharmacies continues to play out in Washington and in courts around the country. Since last summer, six drug companies – Eli Lilly, Novo Nordisk, … [Read more...]
Research Demonstrates 340B Hospitals’ Work to Serve the Underserved
June 25, 2021– Tens of millions of people in the U.S. who are living with chronic diseases require access to regular care and support to help them manage their conditions and live their best possible lives. For too many patients of color, those living with disabilities, and those who have low incomes, the broader health care system often falls short in providing them the care … [Read more...]
The Human Toll of Drug Company Restrictions on 340B
May 26, 2021– Anne Webster knew last fall how bad things would get for many of her patients when the drug company Eli Lilly unilaterally pulled out of offering discounts through the 340B drug pricing program on medications dispensed at community pharmacies. As the nurse practitioner at the endocrinology clinic for UnityPoint Health Methodist in Peoria, Ill., she cares for many … [Read more...]
New Federal 340B Order Is Major Step Toward Restoring Drug Discounts
May 19, 2021– The Health Resources & Services Administration (HRSA) has taken decisive action to put a stop to the actions of six drug companies that are denying 340B drug pricing program discounts for medications dispensed at community pharmacies. The action could lead to the end of a nearly year-long dispute pitting for-profit pharmaceutical companies against nonprofit … [Read more...]
More States Acting To Protect 340B Safety-Net Hospitals
May 12, 2021– Faced with increasing threats from some pharmaceutical benefit managers (PBMs) and drug companies, supporters of the 340B drug pricing program have turned to state governments for protection and are finding increasing support in the form of new protective laws thanks to the work of 340B advocates in the states. To date, 11 states have enacted important … [Read more...]